No Data
No Data
Press Release: MediPharm Labs Announces Voting Results From the 2024 Annual Meeting of Shareholders
MediPharm Labs Announces Voting Results From the 2024 Annual Meeting of Shareholders PR Newswire TORONTO, June 26, 2024 TORONTO, June 26, 2024 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX
MediPharm Labs Corp. Brief: Anticipates Further Improvement on Profitability in 2024 With Plans Being Implemented to Improve Adjusted EBITDA by a Further $1-$2 Million
06:25 AM EDT, 05/15/2024 (MT Newswires) -- MediPharm Labs Corp. Brief: Anticipates further improvement on profitability in 2024 with plans being implemented to improve Adjusted EBITDA by a further $1-
MediPharm Labs Corp. Brief: Revenue Increased 67% to $9.8 Million During the Three Months Ended March 31, 2024, Versus Revenue for the Same Quarter in 2023 of $5.8 Million
06:19 AM EDT, 05/15/2024 (MT Newswires) -- MediPharm Labs Corp. Brief: Revenue increased 67% to $9.8 Million during the three months ended March 31, 2024, versus revenue for the same quarter in 2023 o
Earnings Call Summary | MEDIPHARM LABS CORP(MEDIF.US) Q4 2023 Earnings Conference
The following is a summary of the MediPharm Labs Corp. (MEDIF) Q4 2023 Earnings Call Transcript:Financial Performance:MediPharm reported Q4 2023 revenue of $9.1 million, a 63% increase compared to the
MediPharm Labs Narrows Q4 Loss, Revenue Grows
MediPharm Labs Corp. (LABS.TO), a pharmaceutical company specializing in precision-based cannabinoids, on Wednesday reported a fourth-quarter net loss of $3 million, or $0.01 per share, narrower than
MediPharm Labs Corp. Brief: Q4 Revenue $9.131 Million; Says Annual Revenue and Adjusted EBITDA Improve by 50%
06:33 AM EDT, 03/27/2024 (MT Newswires) -- MediPharm Labs Corp. Brief: Q4 Revenue $9.131 Million; Says Annual Revenue and Adjusted EBITDA Improve by 50%